Skip to content

Advertisement

  • Poster presentation
  • Open Access

Influence of aetiology of acute respiratory distress syndrome and early differences in oxygenation on outcome

  • M Shankar-Hari1,
  • CI Olvera2,
  • S Webb2,
  • S Phelps2,
  • S Batson2,
  • A Puddicome2,
  • R Marshall2,
  • D Howell2 and
  • G Bellingan2
Critical Care201014(Suppl 1):P190

https://doi.org/10.1186/cc8422

Published: 1 March 2010

Keywords

Hospital MortalityAcute Respiratory Distress SyndromeAcute Respiratory Distress Syndrome PatientInterventional TrialHospital Outcome

Introduction

Studies evaluating the relationship between the severity of hypoxemia in patients with acute respiratory distress syndrome (ARDS) and hospital outcome have not found a consistent outcome association. We hypothesized that severity of hypoxemia on admission after optimal ventilation may predict hospital outcome if the ARDS patients are categorised based on the primary etiology: pulmonary ARDS (ARDSp) and extra pulmonary ARDS (ARDSexp). Our aim was therefore to ascertain the relationship between hospital outcome and the severity of hypoxemia in patients with early ARDS (days 1 to 3 following admission) after categorising based on etiology.

Methods

We used a prospective cohort study design and enrolled 151 consecutive patients with a primary diagnosis of ARDS on the day of admission, admitted over a 2-year period to our adult general ICU. Patients enrolled in other clinical interventional trials were excluded from the study. Protocol-based management of mechanical ventilation was used to achieve optimal ventilation. Two authors independently designated patients as ARDSp or ARDSexp and a third reviewed any conflicts (only four cases). Patients were then subcategorised by severity of hypoxaemia based on PaO2/FiO2 ratio (P/F ratio) intervals. All other clinical interventions were at the discretion of treating clinician.

Results

The hospital mortality in all patients included in the study (n = 151) with ARDS was 44.1%. The patients classified as ARDSp had a higher hospital mortality (50.6%) compared with ARDSexp (36.4%), but the difference was not statistically significant (P = 0.12). Nonsurvivors with ARDSp had a significantly lower P/F ratio on day 1 of ARDS diagnosis compared with survivors (12.05 ± 4.46 vs 15.39 ± 4.97 kPa; P = 0.002), a relationship not observed with ARDSexp. This association between mortality and hypoxaemia in early ARDSp persisted at even more serve levels of hypoxaemia (<15 kPa, <12.5 kPa, and <10 kPa; P = 0.01, P = 0.003 and P = 0.002, respectively), while in ARDSexp the effect of hypoxaemia on mortality was not observed.

Conclusions

Our findings indicate that the hypoxaemia burden as assessed by P/F ratio intervals despite optimal ventilatory support on the day of ICU admission predicts increased risk of death in ARDSp; but not in ARDSexp. Interventional trials need to account for the influence of etiology and hypoxaemia burden on outcome prior to concluding this as a negative intervention.

Authors’ Affiliations

(1)
Guy's and St Thomas' NHS Foundation Trust, London, UK
(2)
University College Hospital, London, UK

Copyright

© BioMed Central Ltd. 2010

Advertisement